NCR3 and urinary bladder neoplasm: Bladder tumor hILC1s had lower expression of NKp30, NKp46, and CD69 compared with hILC2s (p < 0.04), (Figure S2; Table S3) indicating a reduced cytotoxic capacity of hILC1s compared with hILC2s.